Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Pulmonary Atelectasis 1 Postural Orthostatic Tachycardia Syndrome 1 Postoperative Complications 1 Pneumonia 1 Pancreatic carcinoma, familial 1 Pancreatic cancer, adult 1 Neoplasms 1 Multiple Myeloma 1 Mastocytosis 1 Lung Cancer Screening 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Esophageal Neoplasms 1 Bronchopulmonary Disease 1 Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 12 Cisplatin 11 Specimen Handling 9 Bevacizumab 7 Brachytherapy 6 Platinum 5 Paclitaxel 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Human Papillomavirus DNA Tests 5 Colposcopy 5 Carboplatin 5 atezolizumab 4 Gemcitabine 4 Fulvestrant 4 Surveys and Questionnaires 3 Radiotherapy 3 Radiation Dose Hypofractionation 3 Radiation 3 Drug Therapy 3 Blood Specimen Collection 3 1,2-diaminocyclohexaneplatinum II citrate 3 tisotumab vedotin 2 palbociclib 2 lenvatinib 2 Topotecan 2 Restraint, Physical 2 Radiotherapy, Intensity-Modulated 2 Pemetrexed 2 Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Mass Screening × 90 days × Clear all

NCT06042543 2026-06-01

EASTER

International Agency for Research on Cancer

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡